-
What Analysts Have To Say About Insmed Following Arikayce Approval
Monday, October 1, 2018 - 6:01pm | 398Insmed Incorporated (NASDAQ: INSM) stock crashed Monday after the U.S. Food & Drug Administration approved the company’s antibiotic Arikayce. In addition to “sell the news” traders moving on following the FDA approval, some sellers are likely concerned about the revelation...
-
Dow Breaks Four-Day Losing Streak As Calm Restores Last Week's Jittery Market
Monday, August 4, 2014 - 4:57pm | 2610U.S. stocks rallied to start the week on a positive note. Investors are looking for bullish signs that can erase last weeks declines, as the S&P 500 had its largest weekly drop since 2012 and the Volatility Index surged more than 30 percent. Portugal's Central Bank plans to spend 4.9...